首页> 外文期刊>Human gene therapy methods. >Reprogramming adipose tissue-derived mesenchymal stem cells into pluripotent stem cells by a mutant adeno-associated viral vector
【24h】

Reprogramming adipose tissue-derived mesenchymal stem cells into pluripotent stem cells by a mutant adeno-associated viral vector

机译:通过突变腺相关病毒载体将脂肪组织来源的间充质干细胞重编程为多能干细胞

获取原文
获取原文并翻译 | 示例

摘要

Induced pluripotent stem (iPS) cells have great potential for personalized regenerative medicine. Although several different methods for generating iPS cells have been reported, improvement of safety and efficiency is imperative. In this study, we tested the feasibility of using a triple tyrosine mutant AAV2 (Y444+500+730F) vector, designated AAV2.3m, to generate iPS cells. We developed a polycistronic rAAV2.3m vector expressing three reprogramming factors, Klf4, Oct4, and Sox2, and then used this vector to infect mouse adipose-derived mesenchymal stem cells (AT-MSCs) to induce the generation of iPS cells. We demonstrated that (1) the triple tyrosine mutant AAV2 vector is able to reprogram mouse adult adipose tissue-derived stem cells into the pluripotent state. Those rAAV2.3m-derived iPS (rAAV2.3m-iPS) cells express endogenous pluripotency-associated genes including Oct4, Sox2, and SSEA-1, and form teratomas containing multiple tissues in vivo; (2) c-myc, an oncogene, is dispensable in rAAV2.3m-mediated cellular reprogramming; and (3) transgene expression is undetectable after reprogramming, whereas vector DNA is detectable, indicating that transgenes are silenced. These results indicated the rAAV vector may have some advantages in generating iPS cells.
机译:诱导多能干(iPS)细胞在个性化再生医学方面具有巨大潜力。尽管已经报道了几种产生iPS细胞的不同方法,但是必须提高安全性和效率。在这项研究中,我们测试了使用名为AAV2.3m的三联酪氨酸突变体AAV2(Y444 + 500 + 730F)载体生成iPS细胞的可行性。我们开发了表达三个重编程因子Klf4,Oct4和Sox2的多顺反子rAAV2.3m载体,然后使用该载体感染小鼠脂肪间充质干细胞(AT-MSC)诱导iPS细胞的生成。我们证明(1)三重酪氨酸突变体AAV2载体能够将小鼠成年脂肪组织来源的干细胞重编程为多能状态。那些rAAV2.3m衍生的iPS(rAAV2.3m-iPS)细胞表达内源多能性相关基因,包括Oct4,Sox2和SSEA-1,并在体内形成含有多种组织的畸胎瘤。 (2)c-myc是一种致癌基因,在rAAV2.3m介导的细胞重编程中不可或缺; (3)重编程后无法检测到转基因表达,而可检测到载体DNA,表明转基因沉默。这些结果表明,rAAV载体在产生iPS细胞方面可能具有一些优势。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号